skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 759  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Crohn's disease
Material Type:
Article
Add to My Research

Crohn's disease

The Lancet (British edition), 2012-11, Vol.380 (9853), p.1590-1605 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60026-9 ;PMID: 22914295 ;CODEN: LANCAO

Full text available

2
Integrin-based therapeutics: biological basis, clinical use and new drugs
Material Type:
Article
Add to My Research

Integrin-based therapeutics: biological basis, clinical use and new drugs

Nature reviews. Drug discovery, 2016-03, Vol.15 (3), p.173-183 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2015.10 ;PMID: 26822833

Full text available

3
Application of Artificial Intelligence to Gastroenterology and Hepatology
Material Type:
Article
Add to My Research

Application of Artificial Intelligence to Gastroenterology and Hepatology

Gastroenterology (New York, N.Y. 1943), 2020-01, Vol.158 (1), p.76-94.e2 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0016-5085 ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2019.08.058 ;PMID: 31593701

Digital Resources/Online E-Resources

4
Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
Material Type:
Article
Add to My Research

Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review

The American journal of gastroenterology, 2011-04, Vol.106 (4), p.674-684 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 2011 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2011.60 ;PMID: 21407178

Full text available

5
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Material Type:
Article
Add to My Research

Inflammatory bowel disease: clinical aspects and established and evolving therapies

The Lancet (British edition), 2007-05, Vol.369 (9573), p.1641-1657 [Peer Reviewed Journal]

Elsevier Ltd ;2007 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)60751-X ;PMID: 17499606

Full text available

6
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
Material Type:
Article
Add to My Research

Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease

Nature reviews. Gastroenterology & hepatology, 2022-06, Vol.19 (6), p.351-366 [Peer Reviewed Journal]

2022. Springer Nature Limited. ;Springer Nature Limited 2022. corrected publication 2022. ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/s41575-021-00574-7 ;PMID: 35165437

Full text available

7
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
Material Type:
Article
Add to My Research

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2021-09, Vol.385 (14), p.1280-1291 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2033617 ;PMID: 34587385

Full text available

8
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

The American journal of gastroenterology, 2015-06, Vol.110 (6), p.802-819 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jun 2015 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2015.120 ;PMID: 25964225

Full text available

9
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Material Type:
Article
Add to My Research

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900750 ;PMID: 31553833

Full text available

10
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Material Type:
Article
Add to My Research

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2017-05, Vol.376 (18), p.1723-1736 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1606910 ;PMID: 28467869

Full text available

11
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Material Type:
Article
Add to My Research

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis

PloS one, 2018-05, Vol.13 (5), p.e0195123-e0195123 [Peer Reviewed Journal]

2018 Singh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Singh et al 2018 Singh et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0195123 ;PMID: 29771924

Full text available

12
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Material Type:
Article
Add to My Research

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

The New England journal of medicine, 2012-08, Vol.367 (7), p.616-624 [Peer Reviewed Journal]

Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1112168 ;PMID: 22894574 ;CODEN: NEJMAG

Full text available

13
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Material Type:
Article
Add to My Research

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2013-08, Vol.369 (8), p.699-710 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215734 ;PMID: 23964932 ;CODEN: NEJMAG

Full text available

14
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Material Type:
Article
Add to My Research

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

The New England journal of medicine, 2013-08, Vol.369 (8), p.711-721 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215739 ;PMID: 23964933 ;CODEN: NEJMAG

Full text available

15
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Material Type:
Article
Add to My Research

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

The American journal of gastroenterology, 2010-02, Vol.105 (2), p.289-297 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Feb 2010 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2009.579 ;PMID: 19861953

Full text available

16
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Material Type:
Article
Add to My Research

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Gut, 2021-04, Vol.70 (4), p.635-640 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0017-5749 ;ISSN: 1468-3288 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-324000 ;PMID: 33472895

Full text available

17
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Material Type:
Article
Add to My Research

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

Clinical gastroenterology and hepatology, 2015-06, Vol.13 (6) [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1542-3565 ;EISSN: 1542-7714 ;DOI: 10.1016/j.cgh.2013.09.006 ;PMID: 24036054

Digital Resources/Online E-Resources

18
Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD
Material Type:
Article
Add to My Research

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Gastroenterology (New York, N.Y. 1943), 2021-04, Vol.160 (5), p.1452-1460.e21 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0016-5085 ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2020.10.065 ;PMID: 33421515

Digital Resources/Online E-Resources

19
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

The American journal of gastroenterology, 2011-04, Vol.106 (4), p.644-659 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 2011 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2011.73 ;PMID: 21407183

Full text available

20
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
Material Type:
Article
Add to My Research

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Gut, 2015-10, Vol.64 (10), p.1539-1545 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307883 ;PMID: 25336114 ;CODEN: GUTTAK

Full text available

Results 1 - 20 of 759  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (683)

Refine My Results

Creation Date 

From To
  1. Before 1997  (20)
  2. 1997 To 2003  (162)
  3. 2004 To 2010  (109)
  4. 2011 To 2018  (248)
  5. After 2018  (221)
  6. More options open sub menu

Resource Type 

  1. Articles  (692)
  2. Patents  (53)
  3. Reports  (6)
  4. Reviews  (5)
  5. Book Chapters  (3)
  6. More options open sub menu

Language 

  1. English  (753)
  2. Japanese  (80)
  3. French  (11)
  4. German  (3)
  5. Norwegian  (3)
  6. Czech  (2)
  7. Hungarian  (1)
  8. Turkish  (1)
  9. Portuguese  (1)
  10. Spanish  (1)
  11. Icelandic  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait